Accelevir Diagnostics is developing methods to detect rare analytes in infectious diseases. To reduce the spread of infectious diseases, assays are required that enable quick and accurate diagnostics. Combining expertise in virology, immunology and assay commercialization, Accelevir is creating scalable assays that can identify difficult to detect pathogens. The technology employed includes droplet-digital PCR, qPCR and sequencing that offer high sensitivity. Accelevir is initially focusing on advancing new assays for persistent HIV-1, the virus that causes AIDS, and other clinically important viral infections. These assays can be used to support basic science research and to evaluate clinical trials. 

<p>Accelevir Diagnostics is developing methods to detect rare analytes in infectious diseases. To reduce the spread of infectious diseases, assays are required that enable quick and accurate diagnostics. Combining expertise in virology, immunology and assay commercialization, Accelevir is creating scalable assays that can identify difficult to detect pathogens. The technology employed includes droplet-digital PCR, qPCR and sequencing that offer high sensitivity. Accelevir is initially focusing on advancing new assays for persistent HIV-1, the virus that causes AIDS, and other clinically important viral infections. These assays can be used to support basic science research and to evaluate clinical trials. </p>


Accelevir Diagnostics

Founded: 2015
Location: Baltimore, MD
Employee range: 1-50
Funding: &lt;10M

Short description:

Drug notes:

Long description:

Jobs: